UR
JAZZ icon

USCA RIA’s Jazz Pharmaceuticals JAZZ Stock Holding History

USCA RIA’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,000
Closed -$352K – 381
2015
Q2 		$352K Sell
2,000
-400
-17% -$71.8K 0.09% 223
2015
Q1 		$415K Buy
2,400
+400
+20% +$68.7K 0.11% 208
2014
Q4 		$327K Hold
2,000
– – 0.09% 239
2014
Q3 		$321K Sell
2,000
-400
-17% -$61.5K 0.1% 228
2014
Q2 		$353K Sell
2,400
-2,926
-55% -$406K 0.12% 193
2014
Q1 		$739K Buy
5,326
+726
+16% +$109K 0.27% 121
2013
Q4 		$582K Buy
4,600
+1,600
+53% +$166K 0.23% 133
2013
Q3 		$276K Buy
+3,000
New +$242K 0.13% 190

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

USCA RIA's JAZZ Position: Q3 2015 in Review

USCA RIA sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 2,000 shares — an estimated $352K sold.

USCA RIA first reported a position in JAZZ in Q3 2013 and held it in 8 quarters. The position peaked at $739K in Q1 2014. 360 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • USCA RIA reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • USCA RIA sold 2,000 Jazz Pharmaceuticals shares in Q3 2015, an estimated $352K.
  • USCA RIA first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 8 quarters.
  • USCA RIA's Jazz Pharmaceuticals position peaked at $739K in Q1 2014.
  • 360 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on USCA RIA's 13F filing for Q3 2015, filed 13 Nov 2015.